Pink Sheet is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Infectious disease-focused Enanta Pharmaceuticals Inc. has netted $56mm in its initial public offering of 4.6mm common shares (including the overallotment) at $14 each, the low end of its intended $14-16 range. The company originally filed for the IPO in November 2012.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?